Results 81 to 90 of about 44,282 (186)

Two Patients With Extremely Long Type 1 Diabetes Duration With Very Few Complications and Remaining Insulin Secretion

open access: yesClinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT We present two patients with > 80 years with type 1 diabetes (T1D), but with minor complications. Their history and risk factors are characterized as are factors conferring resilience against angiopathy. Amazingly, both had clearly detectable C‐peptide.
Åke Sjöholm, Daniel Espes
wiley   +1 more source

Inhibition of central angiotensin-converting enzyme with enalapril protects the brain from ischemia/reperfusion injury in normotensive rat [PDF]

open access: yes
Background and the Purpose of the study: Central Angiotensin Converting Enzyme (ACE) has an important role on cerebral microcirculation and metabolism.
دهقان, غلامعباس   +1 more
core  

Higher persistence with valsartan compared with enalapril in daily practice

open access: yesVascular Health and Risk Management, 2008
Satu J Siiskonen1, Nancy S Breekveldt-Postma1, Gábor Vincze2, Zeba M Khan3, Joëlle A Erkens1, Ron MC Herings11PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands; 2Novartis Pharma AG, Basel, Switzerland; 3Novartis ...
Satu J Siiskonen   +5 more
doaj  

Kidney function in the very elderly with hypertension: data from the hypertension in the very elderly (HYVET) trial.

open access: yes, 2013
BACKGROUND: numerous reports have linked impaired kidney function to a higher risk of cardiovascular events and mortality. There are relatively few data relating to kidney function in the very elderly. METHODS: the Hypertension in the Very Elderly Trial (
Beckett, Nigel   +10 more
core   +1 more source

INFLUENCE OF ENALAPRIL, DIGOXIN, ATENOLOL AND DILTIAZEM ON LIPID PEROXIDATION IN EXPERIMENTAL MODEL OF COMPLEX METABOLIC DISORDERS

open access: yesРациональная фармакотерапия в кардиологии, 2016
Aim. To study influence of enalapril, digoxin, atenolol and diltiazem on lipid peroxidation and antioxidative protection in experimental disorders of glucose and lipid metabolism.Material and methods.
A. A. Usanova   +3 more
doaj   +1 more source

Enalapril therapy and thrombotic and inflammatory abnormalities in essential arterial hypertension

open access: yesКардиоваскулярная терапия и профилактика, 2005
Aim. During enalapril therapy in essential arterial hypertension (EAH) patients, to assess correction of the factors determining arterial thrombosis and inflammatory changes in arterial wall. Material and methods.
O. M. Moiseeva   +3 more
doaj  

Enalapril e captopril revertem o edema e a hiperplasia renais causados pelo antimoniato de N-metilglucamina em camundongos C57BL/6

open access: yesArquivo Brasileiro de Medicina Veterinária e Zootecnia, 2016
The aim of this study was to verify whether enalapril and captopril would reverse the renal damage caused by N-methylglucamine antimoniate in C57BL/6 mice. We used inbred C57BL/6 female mice, obtained from the Oswaldo Cruz Foundation (FIOCRUZ), Salvador,
S.S. Oliveira   +3 more
doaj   +1 more source

Synergistic effects of cardiac resynchronization therapy and drug up-titration in heart failure. is this enough? [PDF]

open access: yes, 2015
This editorial refers to ‘Optimization of heart failure medication after cardiac resynchronization therapy and the impact on long-term survival’, by C.T.
FRANCIA, Pietro, VOLPE, Massimo
core   +1 more source

Gene Expression in Experimental Aortic Coarctation and Repair: Candidate Genes for Therapeutic Intervention? [PDF]

open access: yes, 2015
Coarctation of the aorta (CoA) is a constriction of the proximal descending thoracic aorta and is one of the most common congenital cardiovascular defects.
Bozdag, Serdar   +5 more
core   +3 more sources

Pancreatic ductal adenocarcinoma [PDF]

open access: yes, 2013
A 61-year-old gentleman who lives with his wife and 20-year-old son, presented to the polyclinic with a four week history of pruritus. On examination he was found to be jaundiced and his LFTs were high.
Bezzina, Sarah, Debattista, Daniel
core  

Home - About - Disclaimer - Privacy